Though M&A Deals in H1 '06 Flat with Last Year, Size of Recent Pacts Could Trigger More Activity | GenomeWeb

BioCommerce Week Index companies spent at least $13 billion on 13 M&A deals during the first half of 2006 (see table) — compared with at least $2 billion on 13 deals in last year's first half. But the size and expected upshot of a couple of these transactions on the broader life sciences market are expected to push others to follow suit.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.